bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company ope...
Q1 2026
May 11, 2026
FY 2025
Mar 16, 2026
Q4 2025
Q3 2025
Nov 14, 2025
Q2 2025
Aug 14, 2025